Table 3.
OS and OS rate in high-risk and low-risk groups according to our model risk score in the training and validation cohort
| Parameter | Training cohort | Validation cohort | ||||
|---|---|---|---|---|---|---|
| High-risk group | Low-risk group | Total | High-risk group | Low-risk group | Total | |
| No. of patients | 86 | 59 | 145 | 28 | 28 | 56 |
| OS | ||||||
| Median | 15.0 | 63.0 | 12.5 | 59.0 | ||
| IQR | 7.0–40.0 | 38.0–74.0 | 7.25–21.50 | 33.50–72.25 | ||
| No. of OS | ||||||
| At 1 year | 51 (59.3%) | 58 (98.1%) | 109 (69.7%) | 16 (57.1%) | 25 (89.3%) | 41 (73.2%) |
| At 3 year | 23 (26.7%) | 45 (76.3%) | 68 (46.9%) | 4 (14.3%) | 20 (71.4%) | 24 (42.9%) |
| At 5 year | 10 (11.6%) | 36 (61.0%) | 46 (31.7%) | 1 (3.6%) | 14 (50.0%) | 15 (26.8%) |
OS overall survival, IQR interquartile range